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ABSTRACT
Kounis syndrome (KS) is a hypersensitivity coronary disorder induced by various
allergens. It is a rare condition which has been reported in every age group (2-90 years)
and in every race and geographic location. Its incidence has been reported to range
from 7.9 to 19.4 per 100,000. The presentation of the detrimental effects of KS on
coronary arteries ranges from vasospastic angina to allergic myocardial infarction.
Drugs are the major iatrogenic cause of KS, but virtually everything in the environment
around us can cause KS. In recent years contrast mediums used in the radiologic
investigation have come forth as a leading cause of anaphylaxis. Gadolinium is a rare
earth metal that is used in contrast mediums for magnetic resonance imaging and is
generally considered to be safe.
This is a case of 52-year-old female who developed KS after receiving gadobenate
dimeglumine, a gadolinium based contrast medium (GBCM) for MRI of the brain as a
work up for metastatic renal cell carcinoma. Her EKG was remarkable for ST elevations
in the inferior leads. Cardiac catheterization was preformed which did not reveal any
significant obstructive coronary artery disease. Patient was treated with anti-histamines,
corticosteroids and norepinephrine after which she recovered and discharged home
stable. GBCM induced KS is very rare and to our knowledge this is the third case of
Kounis syndrome reported in association with gadobenate dimeglumine.
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INTRODUCTION
Coronary vasospasm is referred to as constriction
of coronary arteries that causes complete occlusion
or near to complete occlusion of an artery leading
to decreased blood flow to the myocardium.1
Anaphylaxis is an immediate allergic reaction
that has the propensity to cause severe coronary
vasospasms.2,3 Anaphylaxis virtually affects all major
systems of the body including the cardiovascular
system making the heart a target organ.4
Kounis syndrome is a hypersensitivity coronary
disorder induced by various allergens.5 It is a rare
condition which has been reported in every age
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group (2-90 years) and in every race and geographic
location. Its incidence has been reported to range
from 7.9 to 19.4 per 100,000.5 In response to an
allergen, inflammatory cells secrete mediators such
a histamine and tryptase causing changes to the
systemic and coronary vasculature. The presentation
of the detrimental effects of KS on coronary arteries
ranges from vasospastic angina to allergic myocardial
infarction.5
Drugs are the major iatrogenic cause of KS, but
virtually everything in the environment around us
can cause KS. In recent years contrast mediums used
in the radiologic investigation have come forth as
a leading cause of anaphylaxis.6,7 Gadolinium is a
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rare earth metal that is used in contrast mediums
for magnetic resonance imaging and is generally
considered to be safe.8 Here we report a very rare
case of KS in response to gadobenate dimeglumine
(a gadolinium based contrast medium), which
is to our knowledge the third case of Kounis
syndrome reported in association with gadobenate
dimeglumine.
CASE PRESENTATION
A 52-year-old female with no known allergies has
past medical history of a unilateral nephrectomy
due to renal cell carcinoma years ago and chronic
kidney disease (CKD). She was recently diagnosed
with locally advanced and recurrent renal cell
carcinoma with metastatic lesion to the left lower
lung and presented to the radiology department
for an MRI brain with contrast. In the MRI suite, the
patient was given gadolinium contrast after which
she developed severe sub-sternal chest pain and
shortness of breath that was associated with nausea
and vomiting. Shortly after that she collapsed
with systolic blood pressure in the 80s so patient
was intubated and given IV fluid boluses. ECG was
done immediately and that showed ST elevations in
inferior leads (Figure 1) and code heart was called.
Right-sided ECG was done which showed right
ventricular infarct with ST elevation in V3R-V6R
(Figure 2). Troponins were checked by emergency
department physician and trended with a peak of
1.12. The patient was emergently transferred to
the cath lab where a left heart catheterization was
performed which demonstrated that the patient
had non-obstructive coronary artery disease with
20% RCA stenosis (Figure 3 & Figure 4); a pulmonary
angiogram was also done which ruled out pulmonary
embolism (Figure 5). While patient was still on the
table of the cath lab, repeat ECG was performed and
showed normal sinus rhythm with the resolution of
ST-segment elevations (Figure 6).
A diagnosis of Kounis syndrome was made and no
percutaneous coronary intervention was performed.
The patient was started on norepinephrine, decadron
and anti-histamines then transferred to the ICU for
further management and observation. During her
stay in the ICU, she was weaned off epinephrine
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infusion and continued on scheduled decadron.
The patient showed signs of improvement and was
eventually extubated on the second day of hospital
stay. An echocardiogram was performed which
showed an ejection fraction of 60-65% with no wall
motion abnormality and normal right ventricular
size and function. The patient remained stable and
was transferred out to the floor and observed for a
day, after which she was discharged home.
DISCUSSION
Myocardial infarction is often associated with
occlusive coronary artery disease (CAD) but
myocardial infarctions in presence of non-obstructed
coronary arteries have been reported to be as high
as 6%.9 Coronary artery spasm is attributed to be a
major cause for the acute coronary syndrome (ACS)
associated with non-obstructed coronary arteries.9 In
1991, Dr. Nicholas Kounis defined Kounis syndrome
[KS] as the occurrence of acute coronary syndrome
in the presence of an allergic reaction.10 KS has three
types: (i) Vasospastic allergic angina-ACS in patients
with no underlying CAD, (ii) Allergic myocardial
infarction-ASC in patients with underlying CAD
and (iii) Stent thrombosis with occluding thrombus
infiltrated by eosinophils-ACS in patients with
established coronary thrombus and stenting.
In 2016 the definition of KS was revised to: the
concurrence of acute coronary syndromes including
coronary spasm, acute myocardial infarction, and
stent thrombosis, with conditions associated with
mast-cell and platelet activation and involving
interrelated and interacting inflammatory cells, such
as macrophages and T-lymphocytes, in the setting
of allergic or hypersensitivity and anaphylactic or
anaphylactoid insults.5
Anaphylaxis is referred to as an immediate allergic
reaction and or hypersensitivity type reaction. It
clinically presents with hemodynamic instability and
respiratory compromise; these entail hypotension,
tachycardia, bronchospasm, rhinorrhea,
conjunctivitis, vasogenic edema, and pruritus.4,6,7
Although the exact mechanism is yet to be
defined, general consensus encompasses release of
vasoactive mediators that include namely histamine,
serotonin, kinins and prostaglandins.4 Gueant-
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FIGURE 1 EKG on Presentation - ST II, III, AVF- Inferior Leads – STEMI

FIGURE 2 Right Sided EKG, ST elevation in Leads V3, V4, V5, V6 and II, III, AVF with reciprocal changes in
AVL

FIGURE 3 Cardiac Catheterization- normal, no
occlusion
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FIGURE 4 Cardiac Catheterization- normal, no
occlusion
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FIGURE 5 Pulmonary angiography, No Pulmonary Embolism visualized

FIGURE 6 EKG 3, pre-discharge

Rodriguez et al discussed potential pathogenic
pathway by which iodinated contrast mediums
cause immediate allergic reactions and delayed
reactions.6
Gadolinium-based contrast mediums (GCMs) are
used for magnetic resonance investigation. The
incidence of hypersensitivity reaction to GCM has
been reported to vary between 0.7% to 2.4% while
severe anaphylactic reaction occurs 0.004 to 0.01%
of patients.11,12 There are various types of GCMs that
are commonly utilized during magnetic resonance
studies. For our patient gadobenate dimeglumine
was being used for an MRI of the brain; it is a linear
agent which is approved by FDA for central nervous
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system MRIs.13 The most common side effects listed
by FDA are nephrogenic systemic fibrosis along
with acute kidney injury and hypersensitivity.
Cardiac arrhythmia is also listed as a side effect due
to QTc prolongation but is not considered to be a
major side effect.13 A post-marketing surveillance
study demonstrated that acute adverse reaction
rate for gadobenate dimeglumine ranged from
0.024% to 15%.14 The potential mechanism by which
gadolinium causes hypersensitivity is not completely
understood, but sensitization to gadolinium due
to previous exposure is considered to be the most
probable cause.7,12,15,16
As per reviewed literature, our patient had
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an increased risk of gadolinium induced
hypersensitivity. Studies have reported that
gadolinium induced hypersensitivity is more
common in women.7,17 Gadolinium is primarily
excreted through the kidney15 and patients with
elevated creatinine have a preponderance to
hypersensitivity reactions. Our patient had a history
of renal cell carcinoma, with an elevated creatinine
of 1.4 and GFR of 44. Lastly, our patient had a remote
history of an MRI with GCMs which probably would
have worked as the sensitizing exposure. A case
report by Singer et al similarly reported previous
MRIs and exposure to gadolinium.15
The mechanism by which ACS occurs in concurrence
with allergic reaction was explained by Dr. Kounis.5
An allergic reaction is initiated when an allergen
binds to the receptor bound IgE on mast cells
or basophils and degranulation of inflammatory
mediators occurs. These mediators are namely:
histamine, chemokines, protease chymase, tryptase,
cathepsin-D, proteoglycans, cytokines, peptides,
growth factors, leukotrienes, thromboxane, platelet
aggregating factor, prostacyclin and tumor necrosis
factors.
The management of KS is challenging because of
the coexistence of two conditions that have high
fatalities. The treatment must be directed towards
restoring circulation to the myocardium and abating
the anaphylaxis. Corticosteroids have an integral
part in countering the effects of anaphylaxis and
despite their controversial use in ACS patients, they
are deemed to be appropriate treatment for KS.
Another group of medications that are considered
to be efficacious are antihistamines; the use of both
H1 and H2 antagonists such as diphenhydramine
(1 to 2mg/kg) and ranitidine (1mg/kg) are advised,
but the provider should keep in mind that
concomitant use of these agents at a high rate
causes hypotension leading to compromise of the
coronary circulation, hence they should be infused
slowly. Lastly, epinephrine can be used as it alleviates
the life-threatening symptoms of anaphylaxis. Its
use in KS is questionable as it has the potential to
aggravate coronary vasospasm thereby potentiating
the ischemia if administered intravenously. Hence,
intramuscular dose of 0.2 to 0.5mg should be given
every 5 to 15 minutes.18
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Treatment of ACS should be provided in accordance
to the American College of Cardiology Foundation
guidelines. The preferred mode for reperfusion
of the myocardium is percutaneous coronary
intervention. Medical management entails use
of aspirin and an additive antiplatelet such as
clopidogrel, prasugrel or any P2Y12 inhibitors only
if there is no contraindication. Symptomatic relief
and resolution of vasospasm can be achieved by
intravenous nitroglycerin and/ or calcium channel
blockers.18,19
CONCLUSION
Gadolinium-based contrast medium is generally
a benign agent but in very rare cases it can lead
to life threating conditions and physicians should
be aware of the detrimental side effects of this
contrast medium and also should be aware of Kounis
syndrome as a potential serious complication of the
GCM.
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